BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24811206)

  • 1. Role of Fc in antibody-mediated protection from ricin toxin.
    Pincus SH; Das A; Song K; Maresh GA; Corti M; Berry J
    Toxins (Basel); 2014 May; 6(5):1512-25. PubMed ID: 24811206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-mediated inhibition of ricin toxin retrograde transport.
    Yermakova A; Klokk TI; Cole R; Sandvig K; Mantis NJ
    mBio; 2014 Apr; 5(2):e00995. PubMed ID: 24713323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Fc fragment of monoclonal antibodies to tetanus toxin neutralization.
    Ghotloo S; Amiri MM; Khoshnoodi J; Abbasi E; Jeddi-Tehrani M; Golsaz-Shirazi F; Shokri F
    Neurotox Res; 2020 Mar; 37(3):578-586. PubMed ID: 31721050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody to ricin a chain hinders intracellular routing of toxin and protects cells even after toxin has been internalized.
    Song K; Mize RR; Marrero L; Corti M; Kirk JM; Pincus SH
    PLoS One; 2013; 8(4):e62417. PubMed ID: 23638075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing activity and protective immunity to ricin toxin conferred by B subunit (RTB)-specific Fab fragments.
    Yermakova A; Mantis NJ
    Toxicon; 2013 Sep; 72():29-34. PubMed ID: 23603317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformation-dependent high-affinity potent ricin-neutralizing monoclonal antibodies.
    Hu WG; Yin J; Chau D; Hu CC; Lillico D; Yu J; Negrych LM; Cherwonogrodzky JW
    Biomed Res Int; 2013; 2013():471346. PubMed ID: 23484120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Highly Efficient Equine-Derived Antibodies for Post-Exposure Treatment of Ricin Intoxications by Vaccination with Monomerized Ricin.
    Falach R; Sapoznikov A; Alcalay R; Aftalion M; Ehrlich S; Makovitzki A; Agami A; Mimran A; Rosner A; Sabo T; Kronman C; Gal Y
    Toxins (Basel); 2018 Nov; 10(11):. PubMed ID: 30424519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production, Characterisation and Testing of an Ovine Antitoxin against Ricin; Efficacy, Potency and Mechanisms of Action.
    Whitfield SJC; Griffiths GD; Jenner DC; Gwyther RJ; Stahl FM; Cork LJ; Holley JL; Green AC; Clark GC
    Toxins (Basel); 2017 Oct; 9(10):. PubMed ID: 29057798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential neutralizing activities of a single domain camelid antibody (VHH) specific for ricin toxin's binding subunit (RTB).
    Herrera C; Vance DJ; Eisele LE; Shoemaker CB; Mantis NJ
    PLoS One; 2014; 9(6):e99788. PubMed ID: 24918772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo neutralization of α-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody.
    Richard G; Meyers AJ; McLean MD; Arbabi-Ghahroudi M; MacKenzie R; Hall JC
    PLoS One; 2013; 8(7):e69495. PubMed ID: 23894495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Fab and F(ab')2 fragments and isotype variants of a recombinant human monoclonal antibody against Shiga toxin 2.
    Akiyoshi DE; Sheoran AS; Rich CM; Richard L; Chapman-Bonofiglio S; Tzipori S
    Infect Immun; 2010 Mar; 78(3):1376-82. PubMed ID: 20086088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations.
    Torgeman A; Ozeri E; Ben David A; Diamant E; Rosen O; Schwartz A; Barnea A; Makovitzki A; Mimran A; Zichel R
    Toxins (Basel); 2017 May; 9(6):. PubMed ID: 28555060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active immunity induced by passive IgG post-exposure protection against ricin.
    Hu CC; Yin J; Chau D; Cherwonogrodzky JW; Hu WG
    Toxins (Basel); 2014 Jan; 6(1):380-93. PubMed ID: 24451844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis.
    Schlesinger JJ; Chapman S
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():217-20. PubMed ID: 7844536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human IgG anti-F(ab')2 antibodies possess rheumatoid factor activity.
    Hunt Gerardo S; Persselin JE; Stevens RH
    Clin Exp Immunol; 1990 Aug; 81(2):293-300. PubMed ID: 1696866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Streptococcal protein G has affinity for both Fab- and Fc-fragments of human IgG.
    Erntell M; Myhre EB; Sjöbring U; Björck L
    Mol Immunol; 1988 Feb; 25(2):121-6. PubMed ID: 3131664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections.
    Oakes JE; Lausch RN
    Infect Immun; 1981 Jul; 33(1):109-14. PubMed ID: 6266961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-ricin toxin human neutralizing antibodies and DMAbs protection against ricin toxin poisoning.
    Yu H; Wu M; Zhao N; Dong M; Wang Y; Yu K; Sun C; Xu N; Ge L; Liu W
    Toxicol Lett; 2023 Jul; 383():152-161. PubMed ID: 37390852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease.
    Collins JJ; Sackie DM; Johnson GR
    Virology; 1983 Apr; 126(1):259-66. PubMed ID: 6573816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin.
    Colombatti M; Johnson VG; Skopicki HA; Fendley B; Lewis MS; Youle RJ
    J Immunol; 1987 May; 138(10):3339-44. PubMed ID: 2437188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.